Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2056-9920
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Spontaneous retinal pigment epithelial tear in type 2 choroidal neovascularization: repair mechanisms following anti-VEGF therapy ; volume:5 ; number:1 ; day:23 ; month:1 ; year:2019 ; pages:1-4 ; date:12.2019
International Journal of Retina and Vitreous ; 5, Heft 1 (23.1.2019), 1-4, 12.2019
- Urheber
-
Casalino, Giuseppe
Sivagnanavel, Vasuki
Dowlut, Samir
Keane, Pearse A.
Chakravarthy, Usha
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s40942-019-0155-1
- URN
-
urn:nbn:de:101:1-2019021422500600583149
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:02 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Casalino, Giuseppe
- Sivagnanavel, Vasuki
- Dowlut, Samir
- Keane, Pearse A.
- Chakravarthy, Usha
- SpringerLink (Online service)
Ähnliche Objekte (12)
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Inflammasome activation aggravates choroidal neovascularization
Pigment epithelium-derived factor (PEDF) alone or in combination with an anti-VEGF drug as a possible treatment of choroidal neovascularization and ischemic ocular diseases
Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
CRISPR/Cas9 mediated specific ablation of vegfa in retinal pigment epithelium efficiently regresses choroidal neovascularization
Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization
Assessment of choroidal osteoma complicating choroidal neovascularization by optical coherence tomography angiography
Secondary choroidal neovascularization due to choroidal osteoma after 9 years follow-up
Dynamic changes in macrophage morphology during the progression of choroidal neovascularization in a laser-induced choroidal neovascularization mouse model
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Inflammasome activation aggravates choroidal neovascularization
Pigment epithelium-derived factor (PEDF) alone or in combination with an anti-VEGF drug as a possible treatment of choroidal neovascularization and ischemic ocular diseases
Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
CRISPR/Cas9 mediated specific ablation of vegfa in retinal pigment epithelium efficiently regresses choroidal neovascularization
Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization
Assessment of choroidal osteoma complicating choroidal neovascularization by optical coherence tomography angiography
Secondary choroidal neovascularization due to choroidal osteoma after 9 years follow-up
Dynamic changes in macrophage morphology during the progression of choroidal neovascularization in a laser-induced choroidal neovascularization mouse model
Intravitreal anti-VEGF treatment for choroidal neovascularization secondary to traumatic choroidal rupture
Inflammasome activation aggravates choroidal neovascularization
Pigment epithelium-derived factor (PEDF) alone or in combination with an anti-VEGF drug as a possible treatment of choroidal neovascularization and ischemic ocular diseases
Myopic choroidal neovascularization with neovascular signal around perforating scleral vessel prone to recur after anti-VEGF therapy
A new model of choroidal neovascularization
Peripapillary choroidal neovascularization in pars planitis
Long-Term Outcomes of High-Dose Conbercept Treatment for Myopic Choroidal Neovascularization and Idiopathic Choroidal Neovascularization
CRISPR/Cas9 mediated specific ablation of vegfa in retinal pigment epithelium efficiently regresses choroidal neovascularization
Erythropoietin Signaling Increases Choroidal Macrophages and Cytokine Expression, and Exacerbates Choroidal Neovascularization
Assessment of choroidal osteoma complicating choroidal neovascularization by optical coherence tomography angiography
Secondary choroidal neovascularization due to choroidal osteoma after 9 years follow-up